Literature DB >> 23402947

Hormonal imbalance in relation to exercise intolerance and ventilatory inefficiency in chronic heart failure.

Varvara Agapitou1, Stavros Dimopoulos, Christos Kapelios, Eleftherios Karatzanos, Christos Manetos, Andreas Georgantas, Argyrios Ntalianis, John Terrovitis, Helen Karga, Serafim Nanas.   

Abstract

BACKGROUND: Skeletal muscle wasting is associated with altered catabolic/anabolic balance and poor prognosis in patients with chronic heart failure (CHF). This study evaluated catabolic and anabolic abnormalities in relation to disease severity in CHF patients.
METHODS: Forty-two stable CHF patients (34 men; aged 56±12 years, body mass index, 27±5 kg/m2) receiving optimal medical treatment underwent incremental symptom-limited cardiopulmonary exercise testing on a cycle ergometer. Blood samples were drawn within 10 days to determine serum cortisol, plasma adrenocorticotropin (ACTH), and serum dehydroepiandrosterone sulfate, insulin-like growth factor 1, growth hormone, and total testosterone in men.
RESULTS: Patients with higher cortisol levels presented with impaired peak oxygen uptake (Vo2 peak: 18.3±3.9 vs. 14.2±3.7 ml/kg/min, p<0.01), ventilatory (Ve) response to exercise (Ve/carbon dioxide output [Vco2] slope: 36±6 vs 30±5, p<0.01), and chronotropic reserve ([peak heart rate [HR]--resting HR/220--age--resting HR]×100%: 40±19 vs. 58±18, p=0.01) compared with those with lower serum cortisol. Cortisol was inversely correlated with Vo2 peak, (r = -0.57; p<0.01) and was correlated with Ve/Vco2 slope (r = 0.47; p<0.01) and chronotropic reserve (r = 0.44; p = 0.017). In multivariate regression analysis, cortisol was an independent predictor of Vo2peak (R2 = 0.365, F = 12.5, SE = 3.4; p≤0.001) and Ve/Vco2 slope (R2 = 0.154; F = 8.5; SE = 5.96; p = 0.006), after accounting for age, body mass index, sex, CHF etiology, creatinine, left ventricular ejection fraction, and ACTH in all patients. In men, cortisol and dehydroepiandrosterone levels were both independent predictors of Vo2peak (R2 = 0.595, F = 24.53, SE = 2.76; p<0.001) after accounting also for all measured hormones, whereas cortisol remained the only independent predictor of Ve/Vco2 slope (R2 = 0.133; F = 6.1; SE = 6.2; p = 0.02).
CONCLUSIONS: Enhanced catabolic status is significantly associated with exercise intolerance, ventilatory inefficiency, and chronotropic incompetence in CHF patients, suggesting a significant contributing mechanism to their limited functional status.
Copyright © 2013 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23402947     DOI: 10.1016/j.healun.2012.12.011

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

Review 1.  Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician.

Authors:  Brandi A Bottiger; Alina Nicoara; Laurie D Snyder; Paul E Wischmeyer; Jacob N Schroder; Chetan B Patel; Mani A Daneshmand; Robert N Sladen; Kamrouz Ghadimi
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-08-09       Impact factor: 2.628

Review 2.  Publication trends in cachexia and sarcopenia in elderly heart failure patients.

Authors:  Jochen Springer; Stefan D Anker
Journal:  Wien Klin Wochenschr       Date:  2016-11-24       Impact factor: 1.704

Review 3.  Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state.

Authors:  Georgios Tzanis; Stavros Dimopoulos; Varvara Agapitou; Serafim Nanas
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 4.  Affective brain areas and sleep-disordered breathing.

Authors:  Ronald M Harper; Rajesh Kumar; Paul M Macey; Mary A Woo; Jennifer A Ogren
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

5.  Testosterone deficiency increases hospital readmission and mortality rates in male patients with heart failure.

Authors:  Marcelo Rodrigues dos Santos; Ana Luiza Carrari Sayegh; Raphaela Vilar Ramalho Groehs; Guilherme Fonseca; Ivani Credidio Trombetta; Antônio Carlos Pereira Barretto; Marco Antônio Arap; Carlos Eduardo Negrão; Holly R Middlekauff; Maria-Janieire de Nazaré Nunes Alves
Journal:  Arq Bras Cardiol       Date:  2015-07-21       Impact factor: 2.000

Review 6.  Skeletal muscle wasting in chronic heart failure.

Authors:  Tsuyoshi Suzuki; Sandra Palus; Jochen Springer
Journal:  ESC Heart Fail       Date:  2018-12-07

7.  Long-Term Effect of an Exercise Training Program on Physical Functioning and Quality of Life in Pulmonary Hypertension: A Randomized Controlled Trial.

Authors:  Olga Kagioglou; Sophia-Anastasia Mouratoglou; George Giannakoulas; Dorothea Kapoukranidou; Maria Anifanti; Asterios Deligiannis; Aelita Skarbaliene; Arturas Razbadauskas; Evangelia Kouidi
Journal:  Biomed Res Int       Date:  2021-02-26       Impact factor: 3.411

8.  A 3-year observation of testosterone deficiency in Chinese patients with chronic heart failure.

Authors:  Ying Han; Weiju Sun; Guizhi Sun; Xiaolu Hou; Zhaowei Gong; Jing Xu; Xiuping Bai; Lu Fu
Journal:  Oncotarget       Date:  2017-08-02

Review 9.  Muscle wasting and sarcopenia in heart failure and beyond: update 2017.

Authors:  Jochen Springer; Joshua-I Springer; Stefan D Anker
Journal:  ESC Heart Fail       Date:  2017-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.